vs

Side-by-side financial comparison of ASTEC INDUSTRIES INC (ASTE) and Enovis CORP (ENOV). Click either name above to swap in a different company.

Enovis CORP is the larger business by last-quarter revenue ($548.9M vs $400.6M, roughly 1.4× ASTEC INDUSTRIES INC). ASTEC INDUSTRIES INC runs the higher net margin — 3.0% vs -104.1%, a 107.0% gap on every dollar of revenue. On growth, ASTEC INDUSTRIES INC posted the faster year-over-year revenue change (11.6% vs -2.2%). Enovis CORP produced more free cash flow last quarter ($29.1M vs $7.4M). Over the past eight quarters, ASTEC INDUSTRIES INC's revenue compounded faster (13.8% CAGR vs 9.8%).

Astec International plc, better known as Astec Power or just Astec, was an international electronics company originally based in Hong Kong that manufactured power supply units and electric power conversion hardware. It was a major vendor of power supply units for computer systems, and for a time it was the largest global manufacturer of power supplies.

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

ASTE vs ENOV — Head-to-Head

Bigger by revenue
ENOV
ENOV
1.4× larger
ENOV
$548.9M
$400.6M
ASTE
Growing faster (revenue YoY)
ASTE
ASTE
+13.7% gap
ASTE
11.6%
-2.2%
ENOV
Higher net margin
ASTE
ASTE
107.0% more per $
ASTE
3.0%
-104.1%
ENOV
More free cash flow
ENOV
ENOV
$21.7M more FCF
ENOV
$29.1M
$7.4M
ASTE
Faster 2-yr revenue CAGR
ASTE
ASTE
Annualised
ASTE
13.8%
9.8%
ENOV

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASTE
ASTE
ENOV
ENOV
Revenue
$400.6M
$548.9M
Net Profit
$12.0M
$-571.1M
Gross Margin
27.3%
59.9%
Operating Margin
5.7%
-101.7%
Net Margin
3.0%
-104.1%
Revenue YoY
11.6%
-2.2%
Net Profit YoY
-43.1%
18.8%
EPS (diluted)
$0.52
$-9.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTE
ASTE
ENOV
ENOV
Q4 25
$400.6M
$548.9M
Q3 25
$350.1M
$564.5M
Q2 25
$330.3M
$558.8M
Q1 25
$329.4M
Q4 24
$359.0M
$561.0M
Q3 24
$291.4M
$505.2M
Q2 24
$345.5M
$525.2M
Q1 24
$309.2M
$516.3M
Net Profit
ASTE
ASTE
ENOV
ENOV
Q4 25
$12.0M
$-571.1M
Q3 25
$-4.2M
$-36.7M
Q2 25
$16.7M
$-56.0M
Q1 25
$14.3M
Q4 24
$21.1M
$-703.2M
Q3 24
$-6.2M
$-31.5M
Q2 24
$-14.0M
$-18.6M
Q1 24
$3.4M
$-72.0M
Gross Margin
ASTE
ASTE
ENOV
ENOV
Q4 25
27.3%
59.9%
Q3 25
24.1%
59.3%
Q2 25
26.7%
59.5%
Q1 25
28.1%
Q4 24
28.7%
54.8%
Q3 24
22.9%
56.7%
Q2 24
23.5%
55.0%
Q1 24
24.9%
57.7%
Operating Margin
ASTE
ASTE
ENOV
ENOV
Q4 25
5.7%
-101.7%
Q3 25
0.3%
-3.0%
Q2 25
6.5%
-8.4%
Q1 25
6.2%
Q4 24
9.7%
-118.5%
Q3 24
-2.5%
-6.3%
Q2 24
-3.1%
-8.4%
Q1 24
2.0%
-6.8%
Net Margin
ASTE
ASTE
ENOV
ENOV
Q4 25
3.0%
-104.1%
Q3 25
-1.2%
-6.5%
Q2 25
5.1%
-10.0%
Q1 25
4.3%
Q4 24
5.9%
-125.4%
Q3 24
-2.1%
-6.2%
Q2 24
-4.1%
-3.5%
Q1 24
1.1%
-13.9%
EPS (diluted)
ASTE
ASTE
ENOV
ENOV
Q4 25
$0.52
$-9.99
Q3 25
$-0.18
$-0.64
Q2 25
$0.72
$-0.98
Q1 25
$0.62
Q4 24
$0.92
$-12.69
Q3 24
$-0.27
$-0.58
Q2 24
$-0.61
$-0.34
Q1 24
$0.15
$-1.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTE
ASTE
ENOV
ENOV
Cash + ST InvestmentsLiquidity on hand
$74.1M
$33.6M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$681.7M
$2.0B
Total Assets
$1.4B
$4.4B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTE
ASTE
ENOV
ENOV
Q4 25
$74.1M
$33.6M
Q3 25
$71.8M
$44.1M
Q2 25
$91.6M
$38.5M
Q1 25
$95.4M
Q4 24
$93.8M
$48.2M
Q3 24
$58.9M
$35.4M
Q2 24
$68.4M
$35.0M
Q1 24
$63.8M
$66.3M
Total Debt
ASTE
ASTE
ENOV
ENOV
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
Stockholders' Equity
ASTE
ASTE
ENOV
ENOV
Q4 25
$681.7M
$2.0B
Q3 25
$668.9M
$2.6B
Q2 25
$674.9M
$2.6B
Q1 25
$653.2M
Q4 24
$637.8M
$2.6B
Q3 24
$631.4M
$3.3B
Q2 24
$633.3M
$3.3B
Q1 24
$650.3M
$3.3B
Total Assets
ASTE
ASTE
ENOV
ENOV
Q4 25
$1.4B
$4.4B
Q3 25
$1.3B
$5.0B
Q2 25
$1.1B
$4.9B
Q1 25
$1.1B
Q4 24
$1.0B
$4.7B
Q3 24
$1.1B
$5.6B
Q2 24
$1.1B
$5.4B
Q1 24
$1.1B
$5.5B
Debt / Equity
ASTE
ASTE
ENOV
ENOV
Q4 25
0.67×
Q3 25
0.54×
Q2 25
0.53×
Q1 25
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTE
ASTE
ENOV
ENOV
Operating Cash FlowLast quarter
$36.1M
$82.6M
Free Cash FlowOCF − Capex
$7.4M
$29.1M
FCF MarginFCF / Revenue
1.8%
5.3%
Capex IntensityCapex / Revenue
7.2%
9.7%
Cash ConversionOCF / Net Profit
3.01×
TTM Free Cash FlowTrailing 4 quarters
$20.7M
$22.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTE
ASTE
ENOV
ENOV
Q4 25
$36.1M
$82.6M
Q3 25
$-8.1M
$47.8M
Q2 25
$12.9M
$-1.6M
Q1 25
$20.5M
Q4 24
$36.6M
$88.3M
Q3 24
$22.5M
$53.6M
Q2 24
$10.9M
$7.8M
Q1 24
$-47.0M
$-36.2M
Free Cash Flow
ASTE
ASTE
ENOV
ENOV
Q4 25
$7.4M
$29.1M
Q3 25
$-12.3M
$3.4M
Q2 25
$9.0M
$-44.9M
Q1 25
$16.6M
Q4 24
$32.1M
$35.1M
Q3 24
$19.9M
$2.4M
Q2 24
$3.3M
$-31.6M
Q1 24
$-52.8M
$-73.1M
FCF Margin
ASTE
ASTE
ENOV
ENOV
Q4 25
1.8%
5.3%
Q3 25
-3.5%
0.6%
Q2 25
2.7%
-8.0%
Q1 25
5.0%
Q4 24
8.9%
6.3%
Q3 24
6.8%
0.5%
Q2 24
1.0%
-6.0%
Q1 24
-17.1%
-14.2%
Capex Intensity
ASTE
ASTE
ENOV
ENOV
Q4 25
7.2%
9.7%
Q3 25
1.2%
7.9%
Q2 25
1.2%
7.7%
Q1 25
1.2%
Q4 24
1.3%
9.5%
Q3 24
0.9%
10.1%
Q2 24
2.2%
7.5%
Q1 24
1.9%
7.2%
Cash Conversion
ASTE
ASTE
ENOV
ENOV
Q4 25
3.01×
Q3 25
Q2 25
0.77×
Q1 25
1.43×
Q4 24
1.73×
Q3 24
Q2 24
Q1 24
-13.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTE
ASTE

Infrastructure Group$208.7M52%
Material Solutions$105.3M26%
Parts And Component Sales$58.3M15%
Other$15.3M4%
Service And Equipment Installation Revenue$6.9M2%
Cargo And Freight$6.1M2%

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

Related Comparisons